The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
Merck drug extends survival in endometrial cancer trial, wins U.S. priority review
Published
Keep reading
Loading…
Published
The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
Keep reading
